Print Page  print  
Home >>  Investor relations >>  Newsroom >>  Overview

Newsroom

View printer-friendly version

Huntsman Announces Second Quarter 2017 Results; Strong Earnings Growth and Operating Cash Flow

THE WOODLANDS, Texas, July 27, 2017 /PRNewswire/ -- 

Second Quarter 2017 Highlights

  • Net income was $183 million compared to $94 million in the prior year period and $92 million in the prior quarter.
  • Adjusted EBITDA was $413 million compared to $325 million in the prior year period and $329 million in the prior quarter.
  • Diluted income per share was $0.69 compared to $0.36 in the prior year period and $0.31 in the prior quarter.
  • Adjusted diluted income per share was $0.85 compared to $0.53 in the prior year period and $0.57 in the prior quarter.
  • Net cash provided by operating activities was $301 million. Free cash flow generation was $251 million.
  • On July 26, 2017, we made a $100 million early repayment of debt on our term loan B due 2019.
  • Our Pigments and Additives division (Venator) launched its initial public offering on July 24, 2017.
  • Our definitive agreement to merge with Clariant remains on track.  We are confident in our ability to achieve in excess of $400 million in annual cost synergies with another $25 million in annual tax savings, creating in excess of $3.5 billion of value for shareholders

 














Three months ended


Six months ended



June 30,


March 31,


June 30,

In millions, except per share amounts


2017


2016


2017


2017


2016












Revenues


$2,616


$2,544


$    2,469


$5,085


$4,899

Pro forma revenues(2)


$2,616


$2,485


$    2,469


$5,085


$4,779












Net income


$   183


$     94


$        92


$   275


$   156

Adjusted net income(1)


$   206


$   126


$      139


$   345


$   214












Diluted income per share


$  0.69


$  0.36


$     0.31


$  1.00


$  0.60

Adjusted diluted income per share(1)


$  0.85


$  0.53


$     0.57


$  1.42


$  0.90












Adjusted EBITDA(1)


$   413


$   325


$      329


$   742


$   599

Pro forma adjusted EBITDA(2)


$   413


$   317


$      329


$   742


$   584












Net cash provided by operating activities


$   301


$   355


$        93


$   394


$   443

Free cash flow(3)


$   251


$   282


$        82


$   333


$   269













See end of press release for footnote explanations











Huntsman Corporation (NYSE: HUN) today reported second quarter 2017 results with revenues of $2,616 million, net income of $183 million and adjusted EBITDA of $413 million. 

Peter R. Huntsman, our President and CEO, commented:

"I am very pleased with the progress made in the second quarter.  Our businesses continue to benefit from solid underlying fundamentals, enhanced free cash flow generation, and our downstream strategy.  We are on pace to achieve earnings growth in each of our business segments in 2017.  I see continued room for further improvement.  Our downstream differentiated businesses continue to do well with MDI urethanes delivering a strong performance. Performance Products continues to recover off of a difficult 2016 and for the first time since 2015 showed growth versus the prior year.  We realized $251 million of free cash flow in the second quarter and $333 million year to date. We target generating in excess of $150 million of free cash flow in the second half, excluding Pigments and Additives. When combining what we have achieved year to date with the remaining year expectation which excludes Pigments and Additives, we are on track to exceed the previously communicated 2017 full year free cash flow target of greater than $450 million.  We have repaid $265 million of debt year to date, including an early repayment of $100 million made yesterday.     

"This is an unprecedented and transformational time for our Company.  This week we launched the initial public offering of Venator, our Pigments and Additives business, the proceeds of which will be used to reduce our debt.  Furthermore, having begun our integration planning with Clariant, we are now more confident than ever in our ability to exceed our stated synergy targets, seamlessly integrate these two complementary organizations and create significant value for the combined company's shareholders.

"Since announcing the transaction, we continue to identify additional integration and complementary geographical opportunities that will allow us to strengthen further our combined businesses including exposure to new downstream markets.  We are highly confident in our ability to exceed $400 million in annual cost synergies and another $25 million in tax savings. This will create in excess of $3.5 billion of value for shareholders which does not give credit to the existing and meaningful commercial opportunities. Our combined balance sheet with pro-forma leverage of under 1.5x will provide great flexibility for growth and enhanced capital return. This transaction is compelling from every aspect and offers significant value creation opportunity to shareholders.  We are highly confident that shareholders will support the transaction as we work to close near year end."

Segment Analysis for 2Q17 Compared to 2Q16

Polyurethanes

The increase in revenues in our Polyurethanes segment for the three months ended June 30, 2017 compared to the same period of 2016 was primarily due to higher average selling prices, partially offset by lower sales volumes. MDI average selling prices increased in response to higher raw material costs and continued strong market conditions. MTBE average selling prices increased primarily as a result of higher pricing for high octane gasoline. MDI and MTBE sales volumes decreased due to the impact of maintenance outages during the second quarter of 2017. The decrease in segment adjusted EBITDA was primarily due to lower MTBE earnings and the impact of maintenance outages, partially offset by higher MDI margins.

Performance Products

The decrease in revenues in our Performance Products segment for the three months ended June 30, 2017 compared to the same period of 2016 was due to lower sales volumes principally because of the sale of the European surfactants business to Innospec Inc. on December 30, 2016, partially offset by higher sales volumes in our remaining businesses as well as higher average selling prices. Average selling prices increased primarily in response to higher raw material costs and favorable change in product mix partially from the sale of the European surfactants business. The increase in segment adjusted EBITDA was primarily due to higher sales volumes in our remaining businesses and lower fixed costs.

Advanced Materials

Revenues in our Advanced Materials segment for the three months ended June 30, 2017 compared to the same period of 2016 remained relatively unchanged as unfavorable product mix was offset by higher sales volumes. Sales volumes increased primarily due to strong growth in the wind market and the Asian electronics and electrical markets, partially offset by our withdrawal from certain low margin business.  The decrease in segment adjusted EBITDA was primarily due to higher raw material costs, partially offset by lower fixed costs.

Textile Effects

The increase in revenues in our Textile Effects segment for the three months ended June 30, 2017 compared to the same period of 2016 was due to higher sales volumes, partially offset by lower average selling prices. Sales volumes increased in both textile chemicals and dyes, particularly in our Asia region. Average selling prices decreased modestly primarily due to competitive market conditions. Segment adjusted EBITDA remained relatively unchanged as lower fixed costs were offset by lower margins.

Pigments and Additives

The decrease in revenues in the Pigments and Additives division for the three months ended June 30, 2017 compared to the same period in 2016 was due to lower sales volumes, partially offset by higher average selling prices. Sales volumes decreased as a result of the fire at our Pori, Finland manufacturing facility. Average selling prices increased primarily due to improved business conditions for titanium dioxide. The increase in segment adjusted EBITDA was primarily due to higher average selling prices for titanium dioxide and lower costs resulting from restructuring savings.  The fire at our Pori facility did not have a material impact on segment adjusted EBITDA as the reduction in adjusted EBITDA was offset by the receipt of business interruption insurance proceeds.

Corporate, LIFO and other

For the three months ended June 30, 2017, segment adjusted EBITDA decreased by $5 million to a loss of $50 million from a loss of $45 million for the same period in 2016. The decrease in segment adjusted EBITDA from Corporate and other resulted primarily from an increase in loss from benzene sales, partially offset by an increase in unallocated foreign currency exchange gain and a decrease in LIFO inventory valuation expense.

Separation Update

Venator launched its initial public offering on July 24, 2017. In preparation for this, earlier this month Venator raised $750 million in debt, which included $375 million in bonds and $375 million in term loans. Additionally, Venator will have a $300 million committed line through a secured asset back facility. Upon completion of the IPO, net proceeds from the offering and Venator debt will be used to reduce Huntsman indebtedness and to pay related fees and expenses. During the third quarter of 2017, it is intended that our interest in Venator will be treated as "Held for Sale", and, therefore, as  discontinued operations on the income statement, and its earnings will be excluded from our adjusted EBITDA starting with our third quarter results.

Liquidity, Capital Resources and Outstanding Debt

As of June 30, 2017, we had $1,293 million of combined cash and unused borrowing capacity compared to $1,208 million as of December 31, 2016.  Year to date, including the $100 million early repayment of debt made on our term loans yesterday, we have repaid $265 million of debt.

During the six months ended June 30, 2017, net of capital reimbursements we spent $146 million on capital expenditures compared to $162 million in 2016. Including Pigments and Additives, we expect to spend approximately $380 million on capital expenditures in 2017, net of capital reimbursements.

Income Taxes

During the three months ended June 30, 2017, we recorded income tax expense of $45 million.  During the same period, we had net cash income tax receipts of $65 million largely because of a $90 million refund received in the second quarter.

In the second quarter 2017, our adjusted effective tax rate was 19%. We expect our 2017 adjusted effective tax rate to be approximately 20% - 25% and our long term adjusted effective tax rate to be approximately 25% - 28%. 

Earnings Conference Call Information

We will hold a conference call to discuss our second quarter 2017 financial results on Thursday, July 27, 2017 at 10:00 a.m. ET.

Call-in numbers for the conference call:

U.S. participants            

(888) 713 - 4211

International participants   

(617) 213 - 4864

Passcode                         

244 268 82#

In order to facilitate the registration process, you may use the following link to pre-register for the conference call. Callers who pre-register will be given a unique PIN to gain immediate access to the call and bypass the live operator. You may pre-register at any time, including up to and after the call start time. To pre-register, please go to: https://www.theconferencingservice.com/prereg/key.process?key=PEW6BPNM6 .

Webcast Information

The conference call will be available via webcast and can be accessed from the company's website at ir.huntsman.com.

Replay Information

The conference call will be available for replay beginning July 27, 2017 and ending August 3, 2017.

Call-in numbers for the replay:  

U.S. participants         

(888) 286 - 8010

International participants  

(617) 801 - 6888

Replay code                   

29385180

Upcoming Conferences

During the third quarter a member of management is expected to present at the Jefferies Industrials Conference on August 9, 2017, the UBS Best in America Conference on September 7, 2017 and KeyBanc Basic Materials Conference on September 13, 2017. A webcast of the presentation, if applicable, along with accompanying materials will be available at ir.huntsman.com.

 

Table 1 -- Results of Operations












Three months ended


Six months ended



June 30,


June 30,

In millions, except per share amounts


2017


2016


2017


2016










Revenues


$2,616


$2,544


$5,085


$4,899

Cost of goods sold


2,095


2,087


4,098


4,026

Gross profit


521


457


987


873

Operating expenses


218


252


477


517

Restructuring, impairment and plant closing costs


10


29


46


42

Business separation expenses


12


-


21


-

Expenses associated with the merger


6


-


6


-

Operating income


275


176


437


314

Interest expense


(47)


(50)


(95)


(100)

Equity in income of investment in unconsolidated affiliates


3


2


3


3

Loss on early extinguishment of debt


(1)


(2)


(1)


(2)

Other (expense) income


(1)


1


1


2

Income before income taxes


229


127


345


217

Income tax expense


(45)


(32)


(68)


(59)

Income from continuing operations


184


95


277


158

Loss from discontinued operations, net of tax(3)


(1)


(1)


(2)


(2)

Net income


183


94


275


156

Net income attributable to noncontrolling interests, net of tax


(16)


(7)


(32)


(13)

Net income attributable to Huntsman Corporation


$   167


$     87


$   243


$   143



















Adjusted EBITDA(1)


$   413


$   325


$   742


$   599

Adjusted net income(1)


$   206


$   126


$   345


$   214



















Basic income per share


$  0.70


$  0.37


$  1.02


$  0.61

Diluted income per share


$  0.69


$  0.36


$  1.00


$  0.60

Adjusted diluted income per share(1)


$  0.85


$  0.53


$  1.42


$  0.90










Common share information:









Basic shares outstanding


238


236


238


236

Diluted shares


244


240


243


238

Diluted shares for adjusted diluted income per share


244


240


243


238











See end of press release for footnote explanations









 

Table 2 -- Results of Operations by Segment
















Three months ended



Six months ended





June 30,


Better /


June 30,


Better /

In millions


2017


2016


(Worse)


2017


2016


(Worse)














Segment Revenues:













Polyurethanes


$1,022


$   976


5%


$1,975


$1,812


9%

Performance Products


561


566


(1)%


1,094


1,102


(1)%

Performance Products, pro forma(2)


561


507


11%


1,094


982


11%

Advanced Materials


260


261


0%


519


527


(2)%

Textile Effects


205


198


4%


393


383


3%

Pigments & Additives


562


576


(2)%


1,099


1,116


(2)%

Corporate and eliminations


6


(33)


n/m


5


(41)


n/m














Total


$2,616


$2,544


3%


$5,085


$4,899


4%

Total, pro forma(2)


$2,616


$2,485


5%


$5,085


$4,779


6%














Segment Adjusted EBITDA(1):













Polyurethanes


$   167


$   171


(2)%


$   311


$   302


3%

Performance Products


102


86


19%


186


178


4%

Performance Products, pro forma(2)


102


78


31%


186


163


14%

Advanced Materials


56


58


(3)%


110


118


(7)%

Textile Effects


24


24


0%


45


42


7%

Pigments & Additives


114


31


268%


183


46


298%

Corporate, LIFO and other


(50)


(45)


(11)%


(93)


(87)


(7)%














Total


$   413


$   325


27%


$   742


$   599


24%

Total, pro forma(2)


$   413


$   317


30%


$   742


$   584


27%















n/m = not meaningful

























See end of press release for footnote explanations












 


Table 3 -- Factors Impacting Sales Revenue















Three months ended




June 30, 2017 vs. 2016




Average Selling Price(a)










Local

Currency


Exchange

Rate


Sales Mix

& Other


Sales

Volume(b)










Total














Polyurethanes


15%


(2)%


10%


(18)%


5%


Polyurethanes, adj


15%


(2)%


7%


(8)%


12%

(e)

Performance Products


6%


(1)%


0%


(6)%


(1)%


Performance Products, adj


3%


(1)%


0%


9%


11%

(c)

Advanced Materials


1%


(1)%


(2)%


2%


0%


Textile Effects


(2)%


(1)%


1%


6%


4%


Pigments & Additives


12%


(2)%


(1)%


(11)%


(2)%


Pigments & Additives, adj


14%


(2)%


(1)%


(1)%


10%

(d)

Total Company


9%


(1)%


7%


(12)%


3%


Total Company, adj


9%


(1)%


5%


(1)%


12%

(c)(d)(e)















Six months ended




June 30, 2017 vs. 2016




Average Selling Price(a)










Local

Currency


Exchange

Rate


Sales Mix

& Other


Sales

Volume(b)










Total














Polyurethanes


13%


(2)%


7%


(9)%


9%


Polyurethanes, adj


14%


(2)%


5%


(4)%


13%

(e)

Performance Products


5%


(1)%


1%


(6)%


(1)%


Performance Products, adj


1%


(1)%


2%


10%


12%

(c)

Advanced Materials


0%


(1)%


0%


(1)%


(2)%


Textile Effects


(2)%


(1)%


(2)%


8%


3%


Pigments & Additives


11%


(2)%


(2)%


(9)%


(2)%


Pigments & Additives, adj


12%


(2)%


(2)%


(1)%


7%

(d)

Total Company


8%


(1)%


5%


(8)%


4%


Total Company, adj


8%


(1)%


3%


0%


10%

(c)(d)(e)




















(a) Excludes sales from tolling arrangements, by-products and raw materials.






(b) Excludes sales from by-products and raw materials.






(c) Pro forma adjusted to exclude the sale of the European differentiated surfactants on December 30, 2016.


(d) Pro forma adjusted to exclude the impact from the fire at our Pori, Finland facility.


(e) Pro forma adjusted to exclude the impact from maintenance outages in 2Q17.




 

Table 4 -- Reconciliation of U.S. GAAP to Non-GAAP Measures


















 Income Tax 






 Diluted Income 




 EBITDA 


Expense


 Net Income 


 Per Share 




Three months ended


Three months ended


Three months ended


Three months ended




June 30,


June 30,


June 30,


June 30,


In millions, except per share amounts


2017


2016


2017


2016


2017


2016


2017


2016




















Net income


$ 183


$   94






$ 183


$  94


$  0.75


$  0.39


Net income attributable to noncontrolling interests


(16)


(7)






(16)


(7)


(0.07)


(0.03)




















Net income attributable to Huntsman Corporation


167


87






167


87


0.69


0.36


Interest expense


47


50














Income tax expense from continuing operations


45


32


(45)


(32)










Income tax benefit from discontinued operations(4)


-


-














Depreciation and amortization


108


109














Acquisition and integration expenses


4


4


-


-


4


4


0.02


0.02


Loss from discontinued operations, net of tax(4)


1


1


 N/A 


 N/A 


1


1


-


-


Gain on disposition of businesses/assets


(9)


-


-


-


(9)


-


(0.04)


-


Loss on early extinguishment of debt


1


2


-


(1)


1


1


-


-


Expenses associated with merger, net of tax


6


-


-


-


6


-


0.02


-


Certain legal settlements and related expenses


1


-


-


-


1


-


-


-


Net plant incident credits


(2)


(7)


-


1


(2)


(6)


(0.01)


(0.03)


Business separation costs


12


-


(2)


-


10


-


0.04


-


Amortization of pension and postretirement actuarial losses


22


17


(4)


(3)


18


14


0.07


0.06


Restructuring, impairment and plant closing costs


10


30


(1)


(5)


9


25


0.04


0.10




















Adjusted(1)


$ 413


$ 325


$ (52)


$ (40)


$ 206


$ 126


$  0.85


$  0.53


Pro forma adjustments(2)


-


$   (8)














Pro forma adjusted EBITDA(1)


$ 413


$ 317
































Adjusted income tax expense(1)










$   52


$  40






Net income attributable to noncontrolling interests, net of tax










16


7
























Adjusted pre-tax income(1)










$ 274


$ 173
























Adjusted effective tax rate










19%


23%






























 Income Tax 






 Diluted Income 




 EBITDA 


Expense


 Net Income 


 Per Share 




Three months ended


Three months ended


Three months ended


Three months ended




March 31,


March 31,


March 31,


March 31,


In millions, except per share amounts


2017


2017


2017


2017




















Net income


$   92








$   92




$  0.38




Net income attributable to noncontrolling interests


(16)








(16)




(0.07)






















Net income attributable to Huntsman Corporation


76








76




0.31




Interest expense


48
















Income tax expense from continuing operations


23




(23)












Income tax benefit from discontinued operations(4)


(1)
















Depreciation and amortization


106
















Acquisition and integration expenses


3




-




3




0.01




Loss from discontinued operations, net of tax(4)


2




 N/A 




1




-




Net plant incident costs


5




(1)




4




0.02




Business separation costs


9




(2)




7




0.03




Amortization of pension and postretirement actuarial losses


22




(4)




18




0.07




Restructuring, impairment and plant closing costs


36




(6)




30




0.12






















Adjusted(1)


$ 329




$ (36)




$ 139




$  0.57




Pro forma adjustments(2)


-
















Pro forma adjusted EBITDA(1)


$ 329


































Adjusted income tax expense(1)










$   36








Net income attributable to noncontrolling interests, net of tax










16


























Adjusted pre-tax income(1)










$ 191


























Adjusted effective tax rate










19%
































 Income Tax 






 Diluted Income 




 EBITDA 


(Expense) Benefit


 Net Income 


 Per Share 




Six months ended


Six months ended


Six months ended


Six months ended




June 30,


June 30,


June 30,


June 30,


In millions, except per share amounts


2017


2016


2017


2016


2017


2016


2017


2016




















Net income


$ 275


$ 156






$ 275


$ 156


$  1.13


$  0.66


Net income attributable to noncontrolling interests


(32)


(13)






(32)


(13)


(0.13)


(0.05)




















Net income attributable to Huntsman Corporation


243


143






243


143


1.00


0.60


Interest expense


95


100














Income tax expense from continuing operations


68


59


(68)


(59)










Income tax benefit from discontinued operations(4)


(1)


(1)














Depreciation and amortization


214


209














Acquisition and integration expenses


7


13


-


(3)


7


10


0.03


0.04


Loss from discontinued operations, net of tax(4)


3


3


 N/A 


 N/A 


2


2


0.01


0.01


Gain on disposition of businesses/assets


(9)


-


-


-


(9)


-


(0.04)


-


Loss on early extinguishment of debt


1


2


-


(1)


1


1


-


-


Expenses associated with merger


6


-


 N/A 


 N/A 


6


-


0.02


-


Certain legal settlements and related expenses


1


1


-


-


1


1


-


-


Net plant incident costs (credits)


3


(6)


(1)


1


2


(5)


0.01


(0.02)


Business separation costs


21


-


(4)


-


17


-


0.07


-


Amortization of pension and postretirement actuarial losses


44


33


(8)


(6)


36


27


0.15


0.11


Restructuring, impairment and plant closing costs


46


43


(7)


(8)


39


35


0.16


0.15




















Adjusted(1)


$ 742


$ 599


$ (88)


$ (76)

#

$ 345


$ 214


$  1.42


$  0.90


Pro forma adjustments(2)


-


$  (15)














Pro forma adjusted EBITDA(1)


$ 742


$ 584
































Adjusted income tax expense(1)










$   88


$  76






Net income attributable to noncontrolling interests, net of tax










32


13
























Adjusted pre-tax income(1)










$ 465


$ 303
























Adjusted effective tax rate










19%


25%

























See end of press release for footnote explanations


















 


 

Table 5 -- Selected Balance Sheet Items











June 30,


March 31,



December 31,

In millions


2017


2017



2016

















Cash


$    520


$      469



$        425

Accounts and notes receivable, net


1,629


1,508



1,435

Inventories


1,520


1,486



1,344

Other current assets


311


372



351

Property, plant and equipment, net


4,228


4,186



4,212

Other assets


1,480


1,467



1,422









Total assets


$  9,688


$    9,488



$     9,189









Accounts payable


$  1,170


$    1,162



$     1,102

Other current liabilities


669


632



616

Current portion of debt


44


61



60

Long-term debt


4,072


4,161



4,135

Other liabilities


1,855


1,823



1,809

Total equity


1,878


1,649



1,467









Total liabilities and equity


$  9,688


$    9,488



$     9,189

 

Table 6 -- Outstanding Debt








June 30,


December 31,

In millions


2017


2016











Debt:





Senior credit facilities


$  1,862


$          1,967

Accounts receivable programs


181


208

Senior notes


1,884


1,812

Variable interest entities


125


128

Other debt


64


80






Total debt - excluding affiliates


4,116


4,195






Total cash


520


425






Net debt- excluding affiliates


$  3,596


$          3,770

 

Table 7 -- Summarized Statement of Cash Flows














Three months ended


Six months ended




June 30,


June 30,


In millions


2017


2016


2017


2016












Total cash at beginning of period(a)


$    469


$218


$ 425


$ 269












Net cash provided by operating activities


301


355


394


443


Net cash used in investing activities


(59)


(73)


(83)


(174)


Net cash used in financing activities


(193)


(115)


(224)


(153)


Effect of exchange rate changes on cash


3


(2)


8


-


Change in restricted cash


(1)


-


-


(2)










-


Total cash at end of period(a)


$    520


$383


$ 520


$ 383












Supplemental cash flow information:










Cash paid for interest


$     (56)


$ (68)


$  (92)


$(103)


Cash received (paid) for income taxes


65


(16)


57


(21)


Cash paid for capital expenditures


(73)


(90)


(147)


(189)


Depreciation and amortization


108


109


214


209




-








Changes in primary working capital:










Accounts and notes receivable


$     (91)


$  15


$(148)


$  (90)


Inventories


(15)


155


(125)


177


Accounts payable


(4)


(25)


73


(56)












Total cash (used in) provided by  primary working capital


$   (110)


$145


$(200)


$   31


































Three months ended


Six months ended




June 30,


June 30,




2017


2016


2017


2016


Free cash flow(3):










Net cash provided by operating activities


$    301


$355


$ 394


$ 443


Capital expenditures


(73)


(90)


(147)


(189)


All other investing activities, excluding acquisition and disposition activities(b)


9


17


59


15


Non-recurring separation costs(c)


14


-


27


-












Total free cash flow 


$    251


$282


$ 333


$ 269






















Adjusted EBITDA


$    413


$325


$ 742


$ 599


Capital expenditures


(73)


(90)


(147)


(189)


Capital reimbursements


-


27


1


27


Insurance reimbursements


(4)


-


50


-


Interest


(56)


(68)


(92)


(103)


Income taxes


65


(16)


57


(21)


Primary working capital change


(110)


145


(200)


31


Restructuring


(16)


(36)


(35)


(56)


Pensions


(31)


(23)


(55)


(45)


Maintenance & other


63


18


12


26












Total free cash flow(3) 


$    251


$282


$ 333


$ 269













(a) Includes restricted cash.










(b) Represents "Acquisition of business, net of cash acquired",  "Cash received from purchase price adjustment for business acquired", and "Proceeds from sale of business/assets".                       

(c) Represents payments associated with one-time costs of the proposed separation of our Pigments & Additives business.


Footnotes   



(1)

We use adjusted EBITDA to measure the operating performance of our business and for planning and evaluating the performance of our business segments.  We provide adjusted net income because we feel it provides meaningful insight for the investment community into the performance of our business.  We believe that net income (loss) is the performance measure calculated and presented in accordance with generally accepted accounting principles in the U.S. ("GAAP") that is most directly comparable to adjusted EBITDA and adjusted net income.  Additional information with respect to our use of each of these financial measures follows:




Adjusted EBITDA, adjusted net income (loss) and adjusted diluted income (loss) per share, as used herein, are not necessarily comparable to other similarly titled measures of other companies.




Adjusted EBITDA is computed by eliminating the following from net income (loss):  (a) net income attributable to noncontrolling interests, net of tax; (b) interest; (c) income taxes; (d) depreciation and amortization; (e) acquisition and integration expenses; (f) EBITDA from discontinued operations; (g) loss (gain) on disposition of businesses/assets; (h) loss on early extinguishment of debt; (i) expenses associated with merger; (j) certain legal settlements and related expenses (k) net plant incident costs (credits); (l) business separation costs; (m) amortization of pension and postretirement actuarial losses (gains); and (n) restructuring, impairment and plant closing costs (credits).  The reconciliation of adjusted EBITDA to net income (loss) is set forth in Table 4 above.




Adjusted net income (loss) and adjusted diluted income (loss) per share are computed by eliminating the after tax impact of the following items from net income (loss: (a) net income attributable to noncontrolling interest; (b) acquisition and integration expenses, purchase accounting adjustments; (c) impact of certain foreign tax credit elections; (d) loss (income) from discontinued operations; (e) discount amortization on settlement financing associated with the terminated merger; (f) loss (gain) on disposition of businesses/assets; (g) loss on early extinguishment of debt; (h) expenses associated with the merger; (i) certain legal settlements and related expenses; (j) net plant incident costs (credits); (k) business separation costs; (l) amortization of pension and postretirement actuarial losses (gains); and  (m) restructuring, impairment and plant closing costs (credits).    The income tax impacts, if any, of each adjusting item represent a ratable allocation of the total difference between the unadjusted tax expense and the total adjusted tax expense, computed without consideration of any adjusting items using a with and without approach.  We do not adjust for changes in tax valuation allowances because we do not believe it provides more meaningful information than is provided under GAAP.  The reconciliation of adjusted net income (loss) to net income (loss) is set forth in Table 4 above.



(2)

Pro forma adjusted to exclude the sale of our European differentiated surfactants business to Innospec on December 30, 2016 as if it had occurred at the beginning of the relevant period.



(3)

Management internally uses a free cash flow measure: (a) to evaluate the Company's liquidity, (b) to evaluate strategic investments, (c) to plan stock buyback and dividend levels and (d) to evaluate the Company's ability to incur and service debt. Free cash flow is not a defined term under U.S. GAAP, and it should not be inferred that the entire free cash flow amount is available for discretionary expenditures. The Company defines free cash flow as cash flow provided by operating activities less cash flow used in investing activities, excluding acquisition/disposition activities and non-recurring separation costs. Free cash flow is typically derived directly from the Company's condensed consolidated statement of cash flows; however, it may be adjusted for items that affect comparability between periods.



(4)

During the first quarter 2010 we closed our Australian styrenics operations; results from associated business are treated as discontinued operations. 

 

About Huntsman:
Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated chemicals with 2016 revenues of approximately $10 billion. Our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. We operate more than 100 manufacturing and R&D facilities in approximately 30 countries and employ approximately 15,000 associates within our 5 distinct business divisions including the Pigments and Additives division. For more information about Huntsman, please visit the company's website at www.huntsman.com.

Social Media:
Twitter: twitter.com/Huntsman_Corp
Facebook
: www.facebook.com/huntsmancorp
LinkedIn
: www.linkedin.com/company/huntsman

Cautionary Statement
This release shall not constitute an offer to sell or the solicitation of an offer to buy securities.  Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

Forward-Looking Statements:
This communication contains certain statements that are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended.  Clariant Ltd ("Clariant") and Huntsman Corporation ("Huntsman") have identified some of these forward-looking statements with words like "believe," "may," "could," "would," "might," "possible," "will," "should," "expect," "intend," "plan," "anticipate," "estimate," "potential," "outlook" or "continue," the negative of these words, other terms of similar meaning or the use of future dates. Forward-looking statements in this communication include, without limitation, statements about the anticipated benefits of the contemplated transaction, including future financial and operating results and expected synergies and cost savings related to the contemplated transaction, the plans, objectives, expectations and intentions of Clariant, Huntsman or the combined company, the expected timing of the completion of the contemplated transaction and information relating to the proposed initial public offering of ordinary shares of Venator Materials PLC. Such statements are based on the current expectations of the management of Clariant or Huntsman, as applicable, are qualified by the inherent risks and uncertainties surrounding future expectations generally, and actual results could differ materially from those currently anticipated due to a number of risks and uncertainties. Neither Clariant nor Huntsman, nor any of their respective directors, executive officers or advisors, provide any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur. Risks and uncertainties that could cause results to differ from expectations include: uncertainties as to the timing of the contemplated transaction; uncertainties as to the approval of Huntsman's stockholders and Clariant's shareholders required in connection with the contemplated transaction; the possibility that a competing proposal will be made; the possibility that the closing conditions to the contemplated transaction may not be satisfied or waived, including that a governmental entity may prohibit, delay or refuse to grant a necessary regulatory approval; the effects of disruption caused by the announcement of the contemplated transaction making it more difficult to maintain relationships with employees, customers, vendors and other business partners; the risk that stockholder litigation in connection with the contemplated transaction may affect the timing or occurrence of the contemplated transaction or result in significant costs of defense, indemnification and liability; ability to refinance existing indebtedness of Clariant or Huntsman in connection with the contemplated transaction; other business effects, including the effects of industry, economic or political conditions outside of the control of the parties to the contemplated transaction; transaction costs; actual or contingent liabilities; disruptions to the financial or capital markets, including with respect to the initial public offering of ordinary shares by Venator Materials PLC or financing activities related to the contemplated transaction; and other risks and uncertainties discussed in Huntsman's filings with the U.S. Securities and Exchange Commission (the "SEC"), including the "Risk Factors" sections of Huntsman's annual report on Form 10-K for the fiscal year ended December 31, 2016 and quarterly report on Form 10-Q for the six months ended June 30, 2017. You can obtain copies of Huntsman's filings with the SEC for free at the SEC's website (www.sec.gov). Forward-looking statements included herein are made only as of the date hereof and neither Clariant nor Huntsman undertakes any obligation to update any forward-looking statements as a result of new information, future developments or otherwise, except as expressly required by law. All forward-looking statements in this communication are qualified in their entirety by this cautionary statement.

NO OFFER OR SOLICITATION

This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities will be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

IMPORTANT ADDITIONAL INFORMATION WILL BE FILED WITH THE SEC

In connection with the contemplated transaction, Clariant intends to file a registration statement on Form F-4 with the SEC that will include the Proxy Statement/Prospectus of Huntsman. The Proxy Statement/Prospectus will also be sent or given to Huntsman stockholders and will contain important information about the contemplated transaction. INVESTORS AND SHAREHOLDERS ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC CAREFULLY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT CLARIANT, HUNTSMAN, THE CONTEMPLATED TRANSACTION AND RELATED MATTERS. Investors and shareholders will be able to obtain free copies of the Proxy Statement/Prospectus (when available) and other documents filed with the SEC by Clariant and Huntsman through the website maintained by the SEC at www.sec.gov.

PARTICIPANTS IN THE SOLICITATION

Huntsman and its directors and executive officers may be deemed to be participants in the solicitation of proxies from Huntsman investors and shareholders in connection with the contemplated transaction. Information about Huntsman's directors and executive officers is set forth in its proxy statement for its 2017 Annual Meeting of Stockholders and its annual report on Form 10-K for the fiscal year ended December 31, 2016. These documents may be obtained for free at the SEC's website at www.sec.gov. Additional information regarding the interests of participants in the solicitation of proxies in connection with the contemplated transactions will be included in the Proxy Statement/Prospectus that Huntsman intends to file with the SEC.

Huntsman Corporation Logo

 

View original content with multimedia:http://www.prnewswire.com/news-releases/huntsman-announces-second-quarter-2017-results-strong-earnings-growth-and-operating-cash-flow-300494963.html

SOURCE Huntsman Corporation